VWF and thrombotic thrombocytopenic purpura: It is used for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) and works by targeting von Willebrand factor (vWF), inhibiting its interaction with platelets, thus preventing the formation of microthrombi.